Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 021023/0956 | |
| Pages: | 4 |
| | Recorded: | 05/29/2008 | | |
| Attorney Dkt #: | UCLAP012 |
| Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME FROM "UAB RESEARCH FOUNDATION" TO "THE UAB RESEARCH FOUNDATION" PREVIOUSLY RECORDED ON REEL 015602 FRAME 0782. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECTED ASSIGNMENT TO CORRECT THE ASSIGNEE PREVIOUSLY RECORDED ON REEL 012456 FRAME 0956. |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/16/2003
|
Application #:
|
09645454
|
Filing Dt:
|
08/24/2000
|
|
Title:
|
ORALLY ADMINISTERED PEPTIDES TO AMELIORATE ATHEROSCLEROSIS
|
|
|
Assignee
|
|
|
|
|
| 701 20TH STREET SOUTH |
| AB 770 |
| BIRMINGHAM, ALABAMA 35294-0107 |
|
|
Correspondence name and address
|
| |
WEAVER AUSTIN VILLENEUVE & SAMPSON LLP
|
| |
P.O. BOX 70250
|
| |
OAKLAND, CA 94612-0250
|
Search Results as of:
05/08/2024 12:18 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
| 
